Tuesday, January 18, 2011

Billion Dollar Bioterror Boondoggle

And the billions keep on coming! 

"$1b effort yields no bioterror defenses; Mass. labs in line to join scaled-back Pentagon program" by Bryan Bender, Globe Staff / January 17, 2011

WASHINGTON — The Pentagon is scaling back one of its largest efforts to develop treatments for troops and civilians infected in a germ warfare attack after a $1 billion, five-year program fell short of its primary goal.

Even the heavy infusion of research cash and a unified effort by university labs and biotech companies from Boston to California were insufficient to break through limitations of genetic science, according to government officials and specialists in biological terrorism.

Instead, the Pentagon’s next $1 billion for the Transformational Medical Technologies program will focus on better ways to identify mutant versions of Ebola, Marburg, and other deadly viruses. Those are among the genetically modified agents that officials fear could be used by terrorists or rogue states against urban or military targets.   

Sorry, I'm no longer falling for false flags carried out by western intelligence organizations.

The continued flow of money, even with the shift in strategy, should help Massachusetts and other states retain jobs and research labs focused on this arena.... 
 
Yeah, liberal old Massachusetts sure makes out well in the AmeriKan warfare state.

The new strategy represents a return to the drawing board for an ambitious program conceived after the Sept. 11 terrorist strikes and subsequent mailing of anthrax to members of Congress and media organizations — events that helped US military planners realize that the nation lacked adequate defenses against bioterrorism....

And which companie$ benefited? 

Also see: The Anthrax Attacks and the AmeriKan MSM

My 9/11 Investigation 

Yeah, it turns out that Muslims didn't do 9/11; Israel did.  

Crystal Franco, a specialist at the Center for Biosecurity at the University of Pittsburgh Medical Center who specializes in biological defense policy, said the project's hurdles also highlight the need for ongoing taxpayer-investment commitments from government....

--more--"